Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CE Research/Coverage Link Not Addressed In House Health Reform Draft

Executive Summary

The draft health reform legislation unveiled jointly by three House committees June 19 does not specifically address the use of comparative effectiveness research in treatment or coverage decisions, which should raise a red flag for the pharmaceutical industry

You may also be interested in...

Delay, Delay, Delay: Republican Health Reform Strategy Mobilizes Into Action

Senate HELP hearing, Senate Finance delay reveal opposition talking points are turning into practice as health reform efforts hit critical phase.

Baucus Comparative Effectiveness Proposal Runs Into Roadblock From Senior Republicans

Finance Committee CER proposal has been in works for over a year and has generally been viewed by industry as best way to approach CER in health care reform.

HELP Health Reform Bill On Fast Track With Gaps To Fill; Dodd Takes Reins

The Senate Health, Education, Labor and Pensions Committee's health care reform bill is headed to markup beginning June 16, although details of key provisions, including establishment of a public insurance option, are still being developed





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts